Charles Schwab’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,913
Closed -$28K 3520
2025
Q1
$28K Sell
22,913
-42,160
-65% -$51.4K ﹤0.01% 3445
2024
Q4
$83.9K Hold
65,073
﹤0.01% 3408
2024
Q3
$179K Hold
65,073
﹤0.01% 3346
2024
Q2
$147K Buy
65,073
+47,660
+274% +$108K ﹤0.01% 3459
2024
Q1
$41.6K Hold
17,413
﹤0.01% 3381
2023
Q4
$28.9K Hold
17,413
﹤0.01% 3451
2023
Q3
$33.4K Hold
17,413
﹤0.01% 3451
2023
Q2
$25.1K Hold
17,413
﹤0.01% 3530
2023
Q1
$36.6K Hold
17,413
﹤0.01% 3405
2022
Q4
$19.7K Hold
17,413
﹤0.01% 3503
2022
Q3
$29K Hold
17,413
﹤0.01% 3440
2022
Q2
$23K Hold
17,413
﹤0.01% 3511
2022
Q1
$29K Hold
17,413
﹤0.01% 3569
2021
Q4
$37K Hold
17,413
﹤0.01% 3533
2021
Q3
$68K Hold
17,413
﹤0.01% 3414
2021
Q2
$56K Sell
17,413
-60,075
-78% -$193K ﹤0.01% 3352
2021
Q1
$169K Sell
77,488
-8,013
-9% -$17.5K ﹤0.01% 3335
2020
Q4
$192K Hold
85,501
﹤0.01% 3262
2020
Q3
$229K Sell
85,501
-7,438
-8% -$19.9K ﹤0.01% 3136
2020
Q2
$285K Buy
92,939
+495
+0.5% +$1.52K ﹤0.01% 3066
2020
Q1
$182K Hold
92,444
﹤0.01% 3028
2019
Q4
$265K Hold
92,444
﹤0.01% 2998
2019
Q3
$340K Buy
92,444
+17,352
+23% +$63.8K ﹤0.01% 2936
2019
Q2
$312K Buy
+75,092
New +$312K ﹤0.01% 2991
2018
Q2
Sell
-21,400
Closed -$102K 3124
2018
Q1
$102K Hold
21,400
﹤0.01% 3037
2017
Q4
$72K Hold
21,400
﹤0.01% 3044
2017
Q3
$46K Hold
21,400
﹤0.01% 3067
2017
Q2
$53K Sell
21,400
-130,900
-86% -$324K ﹤0.01% 3094
2017
Q1
$351K Buy
+152,300
New +$351K ﹤0.01% 2770
2015
Q2
Sell
-26,400
Closed -$89K 3101
2015
Q1
$89K Hold
26,400
﹤0.01% 3041
2014
Q4
$92K Hold
26,400
﹤0.01% 3069
2014
Q3
$133K Hold
26,400
﹤0.01% 3023
2014
Q2
$365K Buy
+26,400
New +$365K ﹤0.01% 2768